VEGFC and melanoma: Moreover, in a subcutaneous (S.C.)murine model using B16/F10 melanoma tumors overexpressing VEGF-C, systemic treatment with 30 mg/kg q.o.d induced over a 50% reduction in the tumors’ volume.